These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38235705)

  • 1. Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.
    Zhang M; Li X; Herman JG; Gao A; Wang Q; Yao Y; Shen F; He K; Guo M
    Clin Transl Gastroenterol; 2024 Mar; 15(3):e00682. PubMed ID: 38235705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
    Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
    Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
    Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
    Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
    Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
    Geißler AL; Geißler M; Kottmann D; Lutz L; Fichter CD; Fritsch R; Weddeling B; Makowiec F; Werner M; Lassmann S
    Oncotarget; 2017 Mar; 8(10):17164-17190. PubMed ID: 28199979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
    Yan W; Wu K; Herman JG; Brock MV; Fuks F; Yang L; Zhu H; Li Y; Yang Y; Guo M
    Epigenetics; 2013 Dec; 8(12):1373-83. PubMed ID: 24149323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.
    Hu S; Cao B; Zhang M; Linghu E; Zhan Q; Brock MV; Herman JG; Mao G; Guo M
    Am J Cancer Res; 2015; 5(2):651-62. PubMed ID: 25973304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer.
    He T; Wang C; Zhang M; Zhang X; Zheng S; Linghu E; Guo M
    Discov Med; 2017 Mar; 23(126):155-162. PubMed ID: 28472608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancers.
    Piazzi G; Selgrad M; Garcia M; Ceccarelli C; Fini L; Bianchi P; Laghi L; D'Angelo L; Paterini P; Malfertheiner P; Chieco P; Boland CR; Bazzoli F; Ricciardiello L
    Br J Cancer; 2013 Apr; 108(8):1750-6. PubMed ID: 23579212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.
    Jiang AC; Buckingham L; Barbanera W; Korang AY; Bishesari F; Melson J
    Clin Epigenetics; 2017; 9():25. PubMed ID: 28293326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASSF1A promotes ATM signaling and
    Gao A; Bai P; Zhang M; Yao Y; Herman JG; Guo M
    Epigenomics; 2023 Nov; 15(22):1205-1220. PubMed ID: 38093706
    [No Abstract]   [Full Text] [Related]  

  • 20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.